These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 11840260)
1. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260 [TBL] [Abstract][Full Text] [Related]
2. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173 [TBL] [Abstract][Full Text] [Related]
3. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693 [TBL] [Abstract][Full Text] [Related]
5. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069 [TBL] [Abstract][Full Text] [Related]
7. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Hulkkonen J; Vilpo L; Hurme M; Vilpo J Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718 [TBL] [Abstract][Full Text] [Related]
10. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia. Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081 [TBL] [Abstract][Full Text] [Related]
11. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819 [TBL] [Abstract][Full Text] [Related]
12. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Boonstra JG; von't Veer MB; Gratama JW J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702 [TBL] [Abstract][Full Text] [Related]
13. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469 [TBL] [Abstract][Full Text] [Related]
14. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia. Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414 [TBL] [Abstract][Full Text] [Related]
15. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555 [TBL] [Abstract][Full Text] [Related]
16. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197 [TBL] [Abstract][Full Text] [Related]
17. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL. Pittner BT; Jelinek DF; Kay NE Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466 [No Abstract] [Full Text] [Related]
19. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331 [TBL] [Abstract][Full Text] [Related]
20. CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data. Hock BD; McKenzie JL; McArthur L; Tansley S; Taylor KG; Fernyhough LJ Intern Med J; 2010 Dec; 40(12):842-9. PubMed ID: 20002855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]